Compare WMS & ALKS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WMS | ALKS |
|---|---|---|
| Founded | 1966 | 1987 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Containers/Packaging | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 8.7B |
| IPO Year | 2014 | 2012 |
| Metric | WMS | ALKS |
|---|---|---|
| Price | $139.08 | $49.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 14 |
| Target Price | ★ $180.63 | $43.43 |
| AVG Volume (30 Days) | 537.9K | ★ 1.7M |
| Earning Date | 05-21-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.49% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 5.44 | N/A |
| Revenue | ★ $3,050,376,000.00 | $1,475,899,000.00 |
| Revenue This Year | $5.23 | $24.26 |
| Revenue Next Year | $12.79 | $4.47 |
| P/E Ratio | $25.37 | ★ N/A |
| Revenue Growth | ★ 5.03 | N/A |
| 52 Week Low | $112.67 | $25.17 |
| 52 Week High | $179.32 | $55.67 |
| Indicator | WMS | ALKS |
|---|---|---|
| Relative Strength Index (RSI) | 42.91 | 43.21 |
| Support Level | $130.46 | $27.78 |
| Resistance Level | $154.50 | $54.77 |
| Average True Range (ATR) | 4.09 | 1.86 |
| MACD | -1.12 | -0.84 |
| Stochastic Oscillator | 15.05 | 16.17 |
Advanced Drainage Systems Inc designs, manufactures and markets water management solutions in the stormwater and onsite wastewater industries, providing superior drainage solutions for use in the construction and agriculture markets. The company's products are used across a broad range of end markets and applications, including non-residential, residential, infrastructure and agriculture applications. It has two reportable segments: Stormwater and Wastewater. It derives the majority of revenue from the Stormwater segment, which manufactures and markets thermoplastic corrugated pipe and complementary products, including single wall pipe, N-12 HDPE pipe, polypropylene pipe, StormTech, Nyloplast, Inserta Tee, water quality filters and structures, and NDS channel drains, and access boxes.
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.